ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase 3 Study to Compare Efficacy and Safety of Masitinib in Combination With Gemcitabine, to Placebo in Combination With Gemcitabine, in Treatment of Patients With Advanced/Metastatic Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00789633
Recruitment Status : Unknown
Verified September 2012 by AB Science.
Recruitment status was:  Active, not recruiting
First Posted : November 13, 2008
Last Update Posted : September 26, 2012
Sponsor:
Information provided by (Responsible Party):
AB Science